-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Neurocrine Biosciences Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Neurocrine Biosciences Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $6.5M.
- Neurocrine Biosciences Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$57.2M, a 220% decline year-over-year.
- Neurocrine Biosciences Inc annual Nonoperating Income (Expense) for 2023 was $81.2M.
- Neurocrine Biosciences Inc annual Nonoperating Income (Expense) for 2022 was -$35.1M, a 3091% decline from 2021.
- Neurocrine Biosciences Inc annual Nonoperating Income (Expense) for 2021 was -$1.1M, a 98% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)